Evidence map›Paper›PMID 40103657›Full record

ArticleInterventional pain medicine2025

Evaluation of fluoroscopically guided transforaminal epidural steroid injections for cervical radiculopathy utilizing patient reported outcome measurement information system as an outcome measure.

Andrew R Stephens, Ramzi El-Hassan, Ben L Laplante, Rajeev K Patel

Abstract read
In one paragraph

Article in Interventional pain medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew R StephensUniversity of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14623, USA.
Ramzi El-HassanUniversity of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14623, USA.
Ben L LaplanteUniversity of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14623, USA.
Rajeev K PatelUniversity of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14623, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical radiculopathy is a common cause of pain. For patients who fail conservative management, a transforaminal epidural steroid injection (TFESI) is an accepted intervention and alternative to decompression surgery. Objective: The purpose of this study was to evaluate the therapeutic effect of TFESIs for patients with cervical radiculopathy. Methods: Adult patients treated at a multidisciplinary, tertiary academic spine center with cervical radicular pain and MRI evidence of corroborative cervical spondylotic foraminal stenosis and who had failed at least 6 weeks of conservative management consisting of medication and physical rehabilitation were included in this study. Patient Reported Outcome Measurement Information System (PROMIS) domains of Physical Function (PF) v1.2/v2.0 and Pain Interference (PI) v1.1 were collected at baseline and at 3-, 6-, and 12-month follow-up visits. Statistical analysis comparing baseline score with follow-up post-procedural PROMIS scores was performed. The percentage of patients who reported improvement exceeding the minimal clinically important difference was calculated for survey responders and for the worst case scenario. Results: 87 patients met inclusion criteria. PROMIS PI at 3-, 6-, and 12-months follow-up statistically improved by 2.2 (95 % confidence interval [CI] 2.1-2.4, p = 0.02), 2.3 (95 % CI 2.1-2.5, p = 0.03), and 2.7 (95 % CI 2.5-3.0, p = 0.03) points, respectively. Follow-up PROMIS PF score did not significantly differ from baseline scores. The percentage of patients that exceeded MCID thresholds of clinical significance was 59 % (95 % CI 47%-70 %) at 3-months, 52 % (95 % CI 41%-63 %) at 6-months, and 60 % (95 % CI 50%-72 %) at 12-months. Worst case scenario analysis demonstrated that 51 % (95 % CI 39%-62 %) of patients exceeded the MCID thresholds at 3-months, 32 % (95 % CI 22%-43 %) at 6-months, and 23 % (95 % CI 13%-33 %) at 12-months. Conclusions: Our study demonstrated that TFESI leads to a long-term improvement up to a year in pain for patients with cervical radiculopathy.

Indexed as

CervicalPROMISRadiculopathySteroid injectionTFESI

Identifiers

PMID40103657
PMCPMC11914747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.